0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Knotless Tissue-Closure Device Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-11A18018
Home | Market Reports | Health| Medical Devices & Equipment
Global Knotless Tissue Closure Device Market Research Report 2024
BUY CHAPTERS

Global Knotless Tissue-Closure Device Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-11A18018
Report
October 2025
Pages:166
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Knotless Tissue-Closure Device Market

The global Knotless Tissue-Closure Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, General Surgery accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Knotless Tissue-Closure Device leading manufacturers including Corza Medical, Johnson & Johnson (Ethicon), Medtronic, Resorba (Advanced Medical Solutions), Meta Biomed, Serag-Wiessner, Dolphin Sutures, DemeTECH, Katsan Medical Devices, Weigao Group, etc., dominate supply; the top five capture approximately % of global revenue, with Corza Medical leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Knotless Tissue-Closure Device market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Knotless Tissue-Closure Device Market Report

Report Metric Details
Report Name Knotless Tissue-Closure Device Market
Segment by Type
  • Unidirectional Suture
  • Bidirectional Suture
Segment by Application
  • General Surgery
  • Obstetrics and Gynecology
  • Orthopedics
  • Urology
  • Plastic Surgery
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Corza Medical, Johnson & Johnson (Ethicon), Medtronic, Resorba (Advanced Medical Solutions), Meta Biomed, Serag-Wiessner, Dolphin Sutures, DemeTECH, Katsan Medical Devices, Weigao Group, Nanjing Polymer Medical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Knotless Tissue-Closure Device study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Knotless Tissue-Closure Device Market report?

Ans: The main players in the Knotless Tissue-Closure Device Market are Corza Medical, Johnson & Johnson (Ethicon), Medtronic, Resorba (Advanced Medical Solutions), Meta Biomed, Serag-Wiessner, Dolphin Sutures, DemeTECH, Katsan Medical Devices, Weigao Group, Nanjing Polymer Medical Technology

What are the Application segmentation covered in the Knotless Tissue-Closure Device Market report?

Ans: The Applications covered in the Knotless Tissue-Closure Device Market report are General Surgery, Obstetrics and Gynecology, Orthopedics, Urology, Plastic Surgery, Others

What are the Type segmentation covered in the Knotless Tissue-Closure Device Market report?

Ans: The Types covered in the Knotless Tissue-Closure Device Market report are Unidirectional Suture, Bidirectional Suture

1 Study Coverage
1.1 Introduction to Knotless Tissue-Closure Device: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Knotless Tissue-Closure Device Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Unidirectional Suture
1.2.3 Bidirectional Suture
1.3 Market Segmentation by Application
1.3.1 Global Knotless Tissue-Closure Device Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 General Surgery
1.3.3 Obstetrics and Gynecology
1.3.4 Orthopedics
1.3.5 Urology
1.3.6 Plastic Surgery
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Knotless Tissue-Closure Device Revenue Estimates and Forecasts 2020-2031
2.2 Global Knotless Tissue-Closure Device Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Knotless Tissue-Closure Device Sales Estimates and Forecasts 2020-2031
2.4 Global Knotless Tissue-Closure Device Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Knotless Tissue-Closure Device Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Knotless Tissue-Closure Device Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Unidirectional Suture Market Size by Manufacturers
3.5.2 Bidirectional Suture Market Size by Manufacturers
3.6 Global Knotless Tissue-Closure Device Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Knotless Tissue-Closure Device Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Knotless Tissue-Closure Device Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Knotless Tissue-Closure Device Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Knotless Tissue-Closure Device Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Knotless Tissue-Closure Device Sales and Revenue by Type (2020-2031)
6.4 North America Knotless Tissue-Closure Device Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Knotless Tissue-Closure Device Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Knotless Tissue-Closure Device Sales and Revenue by Type (2020-2031)
7.4 Europe Knotless Tissue-Closure Device Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Knotless Tissue-Closure Device Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Knotless Tissue-Closure Device Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Knotless Tissue-Closure Device Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Knotless Tissue-Closure Device Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Knotless Tissue-Closure Device Sales and Revenue by Type (2020-2031)
9.4 Central and South America Knotless Tissue-Closure Device Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Knotless Tissue-Closure Device Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Knotless Tissue-Closure Device Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Knotless Tissue-Closure Device Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Knotless Tissue-Closure Device Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Corza Medical
11.1.1 Corza Medical Corporation Information
11.1.2 Corza Medical Business Overview
11.1.3 Corza Medical Knotless Tissue-Closure Device Product Models, Descriptions and Specifications
11.1.4 Corza Medical Knotless Tissue-Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Corza Medical Knotless Tissue-Closure Device Sales by Product in 2024
11.1.6 Corza Medical Knotless Tissue-Closure Device Sales by Application in 2024
11.1.7 Corza Medical Knotless Tissue-Closure Device Sales by Geographic Area in 2024
11.1.8 Corza Medical Knotless Tissue-Closure Device SWOT Analysis
11.1.9 Corza Medical Recent Developments
11.2 Johnson & Johnson (Ethicon)
11.2.1 Johnson & Johnson (Ethicon) Corporation Information
11.2.2 Johnson & Johnson (Ethicon) Business Overview
11.2.3 Johnson & Johnson (Ethicon) Knotless Tissue-Closure Device Product Models, Descriptions and Specifications
11.2.4 Johnson & Johnson (Ethicon) Knotless Tissue-Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Johnson & Johnson (Ethicon) Knotless Tissue-Closure Device Sales by Product in 2024
11.2.6 Johnson & Johnson (Ethicon) Knotless Tissue-Closure Device Sales by Application in 2024
11.2.7 Johnson & Johnson (Ethicon) Knotless Tissue-Closure Device Sales by Geographic Area in 2024
11.2.8 Johnson & Johnson (Ethicon) Knotless Tissue-Closure Device SWOT Analysis
11.2.9 Johnson & Johnson (Ethicon) Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Knotless Tissue-Closure Device Product Models, Descriptions and Specifications
11.3.4 Medtronic Knotless Tissue-Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Medtronic Knotless Tissue-Closure Device Sales by Product in 2024
11.3.6 Medtronic Knotless Tissue-Closure Device Sales by Application in 2024
11.3.7 Medtronic Knotless Tissue-Closure Device Sales by Geographic Area in 2024
11.3.8 Medtronic Knotless Tissue-Closure Device SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 Resorba (Advanced Medical Solutions)
11.4.1 Resorba (Advanced Medical Solutions) Corporation Information
11.4.2 Resorba (Advanced Medical Solutions) Business Overview
11.4.3 Resorba (Advanced Medical Solutions) Knotless Tissue-Closure Device Product Models, Descriptions and Specifications
11.4.4 Resorba (Advanced Medical Solutions) Knotless Tissue-Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Resorba (Advanced Medical Solutions) Knotless Tissue-Closure Device Sales by Product in 2024
11.4.6 Resorba (Advanced Medical Solutions) Knotless Tissue-Closure Device Sales by Application in 2024
11.4.7 Resorba (Advanced Medical Solutions) Knotless Tissue-Closure Device Sales by Geographic Area in 2024
11.4.8 Resorba (Advanced Medical Solutions) Knotless Tissue-Closure Device SWOT Analysis
11.4.9 Resorba (Advanced Medical Solutions) Recent Developments
11.5 Meta Biomed
11.5.1 Meta Biomed Corporation Information
11.5.2 Meta Biomed Business Overview
11.5.3 Meta Biomed Knotless Tissue-Closure Device Product Models, Descriptions and Specifications
11.5.4 Meta Biomed Knotless Tissue-Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Meta Biomed Knotless Tissue-Closure Device Sales by Product in 2024
11.5.6 Meta Biomed Knotless Tissue-Closure Device Sales by Application in 2024
11.5.7 Meta Biomed Knotless Tissue-Closure Device Sales by Geographic Area in 2024
11.5.8 Meta Biomed Knotless Tissue-Closure Device SWOT Analysis
11.5.9 Meta Biomed Recent Developments
11.6 Serag-Wiessner
11.6.1 Serag-Wiessner Corporation Information
11.6.2 Serag-Wiessner Business Overview
11.6.3 Serag-Wiessner Knotless Tissue-Closure Device Product Models, Descriptions and Specifications
11.6.4 Serag-Wiessner Knotless Tissue-Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Serag-Wiessner Recent Developments
11.7 Dolphin Sutures
11.7.1 Dolphin Sutures Corporation Information
11.7.2 Dolphin Sutures Business Overview
11.7.3 Dolphin Sutures Knotless Tissue-Closure Device Product Models, Descriptions and Specifications
11.7.4 Dolphin Sutures Knotless Tissue-Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Dolphin Sutures Recent Developments
11.8 DemeTECH
11.8.1 DemeTECH Corporation Information
11.8.2 DemeTECH Business Overview
11.8.3 DemeTECH Knotless Tissue-Closure Device Product Models, Descriptions and Specifications
11.8.4 DemeTECH Knotless Tissue-Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 DemeTECH Recent Developments
11.9 Katsan Medical Devices
11.9.1 Katsan Medical Devices Corporation Information
11.9.2 Katsan Medical Devices Business Overview
11.9.3 Katsan Medical Devices Knotless Tissue-Closure Device Product Models, Descriptions and Specifications
11.9.4 Katsan Medical Devices Knotless Tissue-Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Katsan Medical Devices Recent Developments
11.10 Weigao Group
11.10.1 Weigao Group Corporation Information
11.10.2 Weigao Group Business Overview
11.10.3 Weigao Group Knotless Tissue-Closure Device Product Models, Descriptions and Specifications
11.10.4 Weigao Group Knotless Tissue-Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Weigao Group Recent Developments
11.11 Nanjing Polymer Medical Technology
11.11.1 Nanjing Polymer Medical Technology Corporation Information
11.11.2 Nanjing Polymer Medical Technology Business Overview
11.11.3 Nanjing Polymer Medical Technology Knotless Tissue-Closure Device Product Models, Descriptions and Specifications
11.11.4 Nanjing Polymer Medical Technology Knotless Tissue-Closure Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Nanjing Polymer Medical Technology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Knotless Tissue-Closure Device Industry Chain
12.2 Knotless Tissue-Closure Device Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Knotless Tissue-Closure Device Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Knotless Tissue-Closure Device Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Knotless Tissue-Closure Device Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Knotless Tissue-Closure Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Knotless Tissue-Closure Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Knotless Tissue-Closure Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Knotless Tissue-Closure Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Knotless Tissue-Closure Device Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Knotless Tissue-Closure Device Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Knotless Tissue-Closure Device Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Knotless Tissue-Closure Device Sales by Region (2020-2025) & (K Units)
 Table 8. Global Knotless Tissue-Closure Device Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Knotless Tissue-Closure Device Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Knotless Tissue-Closure Device Sales Share by Manufacturers (2020-2025)
 Table 12. Global Knotless Tissue-Closure Device Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Knotless Tissue-Closure Device Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Knotless Tissue-Closure Device by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knotless Tissue-Closure Device as of 2024)
 Table 16. Global Knotless Tissue-Closure Device Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Knotless Tissue-Closure Device Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Knotless Tissue-Closure Device Manufacturing Base and Headquarters
 Table 19. Global Knotless Tissue-Closure Device Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Knotless Tissue-Closure Device Sales by Type (2020-2025) & (K Units)
 Table 23. Global Knotless Tissue-Closure Device Sales by Type (2026-2031) & (K Units)
 Table 24. Global Knotless Tissue-Closure Device Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Knotless Tissue-Closure Device Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Knotless Tissue-Closure Device ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Knotless Tissue-Closure Device Sales by Application (2020-2025) & (K Units)
 Table 29. Global Knotless Tissue-Closure Device Sales by Application (2026-2031) & (K Units)
 Table 30. Knotless Tissue-Closure Device High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Knotless Tissue-Closure Device Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Knotless Tissue-Closure Device Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Knotless Tissue-Closure Device ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Knotless Tissue-Closure Device Growth Accelerators and Market Barriers
 Table 37. North America Knotless Tissue-Closure Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Knotless Tissue-Closure Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Knotless Tissue-Closure Device Growth Accelerators and Market Barriers
 Table 40. Europe Knotless Tissue-Closure Device Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Knotless Tissue-Closure Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Knotless Tissue-Closure Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Knotless Tissue-Closure Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Knotless Tissue-Closure Device Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Knotless Tissue-Closure Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Knotless Tissue-Closure Device Investment Opportunities and Key Challenges
 Table 47. Central and South America Knotless Tissue-Closure Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Knotless Tissue-Closure Device Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Knotless Tissue-Closure Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Corza Medical Corporation Information
 Table 51. Corza Medical Description and Major Businesses
 Table 52. Corza Medical Product Models, Descriptions and Specifications
 Table 53. Corza Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Corza Medical Sales Value Proportion by Product in 2024
 Table 55. Corza Medical Sales Value Proportion by Application in 2024
 Table 56. Corza Medical Sales Value Proportion by Geographic Area in 2024
 Table 57. Corza Medical Knotless Tissue-Closure Device SWOT Analysis
 Table 58. Corza Medical Recent Developments
 Table 59. Johnson & Johnson (Ethicon) Corporation Information
 Table 60. Johnson & Johnson (Ethicon) Description and Major Businesses
 Table 61. Johnson & Johnson (Ethicon) Product Models, Descriptions and Specifications
 Table 62. Johnson & Johnson (Ethicon) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Johnson & Johnson (Ethicon) Sales Value Proportion by Product in 2024
 Table 64. Johnson & Johnson (Ethicon) Sales Value Proportion by Application in 2024
 Table 65. Johnson & Johnson (Ethicon) Sales Value Proportion by Geographic Area in 2024
 Table 66. Johnson & Johnson (Ethicon) Knotless Tissue-Closure Device SWOT Analysis
 Table 67. Johnson & Johnson (Ethicon) Recent Developments
 Table 68. Medtronic Corporation Information
 Table 69. Medtronic Description and Major Businesses
 Table 70. Medtronic Product Models, Descriptions and Specifications
 Table 71. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Medtronic Sales Value Proportion by Product in 2024
 Table 73. Medtronic Sales Value Proportion by Application in 2024
 Table 74. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 75. Medtronic Knotless Tissue-Closure Device SWOT Analysis
 Table 76. Medtronic Recent Developments
 Table 77. Resorba (Advanced Medical Solutions) Corporation Information
 Table 78. Resorba (Advanced Medical Solutions) Description and Major Businesses
 Table 79. Resorba (Advanced Medical Solutions) Product Models, Descriptions and Specifications
 Table 80. Resorba (Advanced Medical Solutions) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Resorba (Advanced Medical Solutions) Sales Value Proportion by Product in 2024
 Table 82. Resorba (Advanced Medical Solutions) Sales Value Proportion by Application in 2024
 Table 83. Resorba (Advanced Medical Solutions) Sales Value Proportion by Geographic Area in 2024
 Table 84. Resorba (Advanced Medical Solutions) Knotless Tissue-Closure Device SWOT Analysis
 Table 85. Resorba (Advanced Medical Solutions) Recent Developments
 Table 86. Meta Biomed Corporation Information
 Table 87. Meta Biomed Description and Major Businesses
 Table 88. Meta Biomed Product Models, Descriptions and Specifications
 Table 89. Meta Biomed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Meta Biomed Sales Value Proportion by Product in 2024
 Table 91. Meta Biomed Sales Value Proportion by Application in 2024
 Table 92. Meta Biomed Sales Value Proportion by Geographic Area in 2024
 Table 93. Meta Biomed Knotless Tissue-Closure Device SWOT Analysis
 Table 94. Meta Biomed Recent Developments
 Table 95. Serag-Wiessner Corporation Information
 Table 96. Serag-Wiessner Description and Major Businesses
 Table 97. Serag-Wiessner Product Models, Descriptions and Specifications
 Table 98. Serag-Wiessner Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Serag-Wiessner Recent Developments
 Table 100. Dolphin Sutures Corporation Information
 Table 101. Dolphin Sutures Description and Major Businesses
 Table 102. Dolphin Sutures Product Models, Descriptions and Specifications
 Table 103. Dolphin Sutures Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Dolphin Sutures Recent Developments
 Table 105. DemeTECH Corporation Information
 Table 106. DemeTECH Description and Major Businesses
 Table 107. DemeTECH Product Models, Descriptions and Specifications
 Table 108. DemeTECH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. DemeTECH Recent Developments
 Table 110. Katsan Medical Devices Corporation Information
 Table 111. Katsan Medical Devices Description and Major Businesses
 Table 112. Katsan Medical Devices Product Models, Descriptions and Specifications
 Table 113. Katsan Medical Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Katsan Medical Devices Recent Developments
 Table 115. Weigao Group Corporation Information
 Table 116. Weigao Group Description and Major Businesses
 Table 117. Weigao Group Product Models, Descriptions and Specifications
 Table 118. Weigao Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Weigao Group Recent Developments
 Table 120. Nanjing Polymer Medical Technology Corporation Information
 Table 121. Nanjing Polymer Medical Technology Description and Major Businesses
 Table 122. Nanjing Polymer Medical Technology Product Models, Descriptions and Specifications
 Table 123. Nanjing Polymer Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Nanjing Polymer Medical Technology Recent Developments
 Table 125. Key Raw Materials Distribution
 Table 126. Raw Materials Key Suppliers
 Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 128. Milestones in Production Technology Evolution
 Table 129. Distributors List
 Table 130. Market Trends and Market Evolution
 Table 131. Market Drivers and Opportunities
 Table 132. Market Challenges, Risks, and Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources


List of Figures
 Figure 1. Knotless Tissue-Closure Device Product Picture
 Figure 2. Global Knotless Tissue-Closure Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Unidirectional Suture Product Picture
 Figure 4. Bidirectional Suture Product Picture
 Figure 5. Global Knotless Tissue-Closure Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. General Surgery
 Figure 7. Obstetrics and Gynecology
 Figure 8. Orthopedics
 Figure 9. Urology
 Figure 10. Plastic Surgery
 Figure 11. Others
 Figure 12. Knotless Tissue-Closure Device Report Years Considered
 Figure 13. Global Knotless Tissue-Closure Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Knotless Tissue-Closure Device Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Knotless Tissue-Closure Device Revenue Market Share by Region (2020-2031)
 Figure 17. Global Knotless Tissue-Closure Device Sales (2020-2031) & (K Units)
 Figure 18. Global Knotless Tissue-Closure Device Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 19. Global Knotless Tissue-Closure Device Sales Market Share by Region (2020-2031)
 Figure 20. Top 5 and Top 10 Manufacturers Knotless Tissue-Closure Device Sales Volume Market Share in 2024
 Figure 21. Global Knotless Tissue-Closure Device Revenue Market Share Ranking (2024)
 Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 23. Unidirectional Suture Revenue Market Share by Manufacturer in 2024
 Figure 24. Bidirectional Suture Revenue Market Share by Manufacturer in 2024
 Figure 25. Global Knotless Tissue-Closure Device Sales Market Share by Type (2020-2031)
 Figure 26. Global Knotless Tissue-Closure Device Revenue Market Share by Type (2020-2031)
 Figure 27. Global Knotless Tissue-Closure Device Sales Market Share by Application (2020-2031)
 Figure 28. Global Knotless Tissue-Closure Device Revenue Market Share by Application (2020-2031)
 Figure 29. North America Knotless Tissue-Closure Device Sales YoY (2020-2031) & (K Units)
 Figure 30. North America Knotless Tissue-Closure Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. North America Top 5 Manufacturers Knotless Tissue-Closure Device Sales Revenue (US$ Million) in 2024
 Figure 32. North America Knotless Tissue-Closure Device Sales Volume (K Units) by Type (2020- 2031)
 Figure 33. North America Knotless Tissue-Closure Device Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 34. North America Knotless Tissue-Closure Device Sales Volume (K Units) by Application (2020-2031)
 Figure 35. North America Knotless Tissue-Closure Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 36. US Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 37. Canada Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 38. Mexico Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 39. Europe Knotless Tissue-Closure Device Sales YoY (2020-2031) & (K Units)
 Figure 40. Europe Knotless Tissue-Closure Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Europe Top 5 Manufacturers Knotless Tissue-Closure Device Sales Revenue (US$ Million) in 2024
 Figure 42. Europe Knotless Tissue-Closure Device Sales Volume (K Units) by Type (2020-2031)
 Figure 43. Europe Knotless Tissue-Closure Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 44. Europe Knotless Tissue-Closure Device Sales Volume (K Units) by Application (2020-2031)
 Figure 45. Europe Knotless Tissue-Closure Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Germany Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 47. France Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 48. U.K. Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 49. Italy Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 50. Russia Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Knotless Tissue-Closure Device Sales YoY (2020-2031) & (K Units)
 Figure 52. Asia-Pacific Knotless Tissue-Closure Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific Top 8 Manufacturers Knotless Tissue-Closure Device Sales Revenue (US$ Million) in 2024
 Figure 54. Asia-Pacific Knotless Tissue-Closure Device Sales Volume (K Units) by Type (2020- 2031)
 Figure 55. Asia-Pacific Knotless Tissue-Closure Device Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 56. Asia-Pacific Knotless Tissue-Closure Device Sales Volume (K Units) by Application (2020-2031)
 Figure 57. Asia-Pacific Knotless Tissue-Closure Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Indonesia Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 59. Japan Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 60. South Korea Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 61. China Taiwan Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 62. India Knotless Tissue-Closure Device Revenue (2020-2031) & (US$ Million)
 Figure 63. Central and South America Knotless Tissue-Closure Device Sales YoY (2020-2031) & (K Units)
 Figure 64. Central and South America Knotless Tissue-Closure Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Central and South America Top 5 Manufacturers Knotless Tissue-Closure Device Sales Revenue (US$ Million) in 2024
 Figure 66. Central and South America Knotless Tissue-Closure Device Sales Volume (K Units) by Type (2021-2031)
 Figure 67. Central and South America Knotless Tissue-Closure Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 68. Central and South America Knotless Tissue-Closure Device Sales Volume (K Units) by Application (2020-2031)
 Figure 69. Central and South America Knotless Tissue-Closure Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 70. Brazil Knotless Tissue-Closure Device Revenue (2020-2025) & (US$ Million)
 Figure 71. Argentina Knotless Tissue-Closure Device Revenue (2020-2025) & (US$ Million)
 Figure 72. Middle East, and Africa Knotless Tissue-Closure Device Sales YoY (2020-2031) & (K Units)
 Figure 73. Middle East and Africa Knotless Tissue-Closure Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 74. Middle East and Africa Top 5 Manufacturers Knotless Tissue-Closure Device Sales Revenue (US$ Million) in 2024
 Figure 75. Middle East and Africa Knotless Tissue-Closure Device Sales Volume (K Units) by Type (2021-2031)
 Figure 76. South America Knotless Tissue-Closure Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 77. Middle East and Africa Knotless Tissue-Closure Device Sales Volume (K Units) by Application (2020-2031)
 Figure 78. Middle East and Africa Knotless Tissue-Closure Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 79. GCC Countries Knotless Tissue-Closure Device Revenue (2020-2025) & (US$ Million)
 Figure 80. Turkey Knotless Tissue-Closure Device Revenue (2020-2025) & (US$ Million)
 Figure 81. Egypt Knotless Tissue-Closure Device Revenue (2020-2025) & (US$ Million)
 Figure 82. South Africa Knotless Tissue-Closure Device Revenue (2020-2025) & (US$ Million)
 Figure 83. Knotless Tissue-Closure Device Industry Chain Mapping
 Figure 84. Regional Knotless Tissue-Closure Device Manufacturing Base Distribution (%)
 Figure 85. Global Knotless Tissue-Closure Device Production Market Share by Region (2020-2031)
 Figure 86. Knotless Tissue-Closure Device Production Process
 Figure 87. Regional Knotless Tissue-Closure Device Production Cost Structure
 Figure 88. Channels of Distribution (Direct Vs Distribution)
 Figure 89. Bottom-up and Top-down Approaches for This Report
 Figure 90. Data Triangulation
 Figure 91. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Peripheral Vascular Support Catheter Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-14O17929
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Ozone Medical Instrument Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28E19710
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Knotless Tissue-Closure Device Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-11A18018
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Medical Device SPD (Supply-Processing-Distribution) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13W20069
Tue Oct 14 00:00:00 UTC 2025

Add to Cart